Lv3
210 积分 2022-07-22 加入
Abstract PS1-10-08: Er riptacs drive tumor selective cell death in post-cdk4/6i resistance settings and demonstrate oral efficacy in cdx and pdx models
3天前
已完结
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer
6天前
已完结
Luciferase-YFP fusion tag with enhanced emission for single-cell luminescence imaging
11天前
已完结
Flow Cytometry-Based Detection and Analysis of BCL-2 Family Proteins and Mitochondrial Outer Membrane Permeabilization (MOMP)
26天前
已完结
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine
26天前
已完结
Apoptotic markers are increased in platelets stored at 37°C
1个月前
已完结
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
1个月前
已完结
PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis
1个月前
已完结
Clinical activity of tazemetostat, an EZH2 inhibitor, among patients with advanced endometrioid endometrial cancer and ovarian clear cell carcinoma with and without ARID1A mutations (NRG-GY014)
1个月前
已关闭
The dTAG system for immediate and target-specific protein degradation
1个月前
已完结
皖公网安备34019202002308
